Botanix Pharmaceuticals Limited
BOT.AX
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.75M
Close$
Share Statistics
| Market cap | $43.75 Million |
|---|---|
| Enterprise Value | $21.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 0.86 |
| Outstanding Shares | 2,386,254,587 |
Return
| Return on Equity | -246.09% |
|---|---|
| Return on Assets | -147.51% |
| Return on Invested Capital | -203.18% |
Valuation & Multiples
| P/E Ratio | -0.43 |
|---|---|
| PEG | 1.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.54 |
| Enterprise Value to EBIT | -0.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$17.00 M
Average shareholder expectationNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$24.95 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Botanix Pharmaceuticals Limited
11 employees
CEO: Howie McKibbon Botanix Pharmaceuticals Limited, an Australian enterprise, is dedicated to the discovery and advancement of novel dermatological and antimicrobial therapeutic agents. The company's central mission involves pioneering innovative treatment...